Ophthotech reported $24.99M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alimera Sciences ALIM:US $ 10.31M 0.9M
Applied Genetic Technologies AGTC:US $ 16.55M 2.31M
Cytrx CYTR:US 2.48M 177.19K
Insmed INSM:US $ 99.66M 18.26M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Novartis NOVN:VX SF 29633M 527M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M